Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026)

Elanco Animal Health has disclosed Free Cash Flow across 10 years of filings, most recently posting -$38.0 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$38.0 million, up 44.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.0 million (down 9.22% YoY), and the FY2025 annual result was $284.0 million, down 27.92% from the prior year.
• Free Cash Flow came in at -$38.0 million for Q1 2026 at Elanco Animal Health, down from $46.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $261.0 million in Q2 2022 to a low of -$169.0 million in Q1 2023.
• The 5-year median for Free Cash Flow is $116.0 million (2023), against an average of $61.9 million.
• Across the five-year window, Free Cash Flow plunged 505.88% in 2022 and jumped 773.68% in 2024, its largest moves.
• Elanco Animal Health's Free Cash Flow stood at -$64.0 million in 2022, then surged by 281.25% to $116.0 million in 2023, then rose by 12.07% to $130.0 million in 2024, then plunged by 64.62% to $46.0 million in 2025, then sank by 182.61% to -$38.0 million in 2026.
• The last three Free Cash Flow figures came in at -$38.0 million (Q1 2026), $46.0 million (Q4 2025), and $127.0 million (Q3 2025), per Business Quant data.